These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6686653)

  • 21. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible DA agonist properties of naloxone.
    Feigenbaum J; Yanai J; Blass R
    Int J Neurosci; 1982 Nov; 17(3):139-44. PubMed ID: 6302020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditioned stereotypy: behavioral specification of the UCS and pharmacological investigation of the neural change.
    Hiroi N; White NM
    Pharmacol Biochem Behav; 1989 Jan; 32(1):249-58. PubMed ID: 2543991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotypy following acute administration of l-alpha-acetylmethadol (LAAM) in the rat.
    Henderson GL; Westkaemper R
    Proc West Pharmacol Soc; 1975; 18():204-7. PubMed ID: 1237140
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopaminergic-cholinergic interactions in naloxone-induced circling in morphine-dependent rats with nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    Eur J Pharmacol; 1976 Jul; 38(1):39-54. PubMed ID: 986306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
    Extein I; Lo C; Goodwin FK; Schoenfeld RI
    Psychiatry Res; 1979 Dec; 1(3):333-9. PubMed ID: 233159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ergometrine on methamphetamine and apomorphine stereotypy in the guinea-pig.
    Balsara JJ; Bapat TR; Gada VP; Nandal NV; Chandorkar AG
    J Pharm Pharmacol; 1985 Jul; 37(7):514-7. PubMed ID: 2863364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that apomorphine and (+)-amphetamine produce different types of circling in rats.
    Cools AR; Scheenen W; Eilam D; Golani I
    Behav Brain Res; 1989 Aug; 34(1-2):111-6. PubMed ID: 2765168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors.
    Kuczenski R; Segal DS
    Brain Res; 1999 Mar; 822(1-2):164-74. PubMed ID: 10082894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
    Cheal M; Kurkulos ME; Silva L
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of fasting on the stereotyped behaviour induced by amphetamine and by apomorphine in the albino rat.
    Fuenmayor LD; Diaz S
    Eur J Pharmacol; 1984 Mar; 99(2-3):153-8. PubMed ID: 6539708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on dopamine kinetics in rat brain tissue under the influence of morphine.
    Kuschinsky K; Celsen B; Huppertz A
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):129-33. PubMed ID: 1172489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitization of male rats to aggressive behavior by apomorphine].
    Allikmets LKh; Vasar EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1982; 32(1):130-5. PubMed ID: 7199793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of gamma-butyrolactone on behavior due to dopaminergic drugs.
    Dougherty GG; Ellinwood EH
    Physiol Behav; 1983 Apr; 30(4):607-12. PubMed ID: 6683846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of naloxone on dopamine uptake and release in vitro in the striatum.
    Feigenbaum JJ; Yanai J; Iser C; Klawans H
    Neuropsychobiology; 1984; 11(2):94-7. PubMed ID: 6483167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1990; 102(2):263-8. PubMed ID: 2274609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPA glutamate receptor activation in the posterior zona incerta inhibits amphetamine- and apomorphine-induced stereotypy.
    Supko DE; Wallace LJ
    Brain Res; 1992 Jul; 584(1-2):213-8. PubMed ID: 1381265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems.
    Randrup A; Mogilnicka E
    Pol J Pharmacol Pharm; 1976; 28(6):551-6. PubMed ID: 1034919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.